Brief: InspireMD Inc Receives Reimbursement Approval For CGUARD Embolic Prevention System From The French National Authority For Health
13/10/2021 14:43
Oct 13 (Reuters) - InspireMD Inc NSPR.O :
* INSPIREMD RECEIVES REIMBURSEMENT APPROVAL FOR CGUARD™
EMBOLIC
PREVENTION SYSTEM FROM THE FRENCH NATIONAL AUTHORITY FOR HEALTH
Source text for Eikon: ID:nGNXKvXV0
Further company coverage: NSPR.O
Recent news on InspireMD
See all newsInspireMD Inc reports results for the quarter ended June 30 - Earnings Summary
InspireMD Q2 revenue beats estimates on international demand
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Q1 revenue jumps 122%, beats estimates on product demand